A Tata Trusts initiative, India Health Fund (IHF) has funded two platforms that are developed to help diagnose multiple diseases. The first innovation developed by Ameliorate Biotech is a fever panel to detect dengue, chikungunya, and malaria, which is a 15-minute test using a single test kit and a single blood sample, eliminating the need of serum/plasma samples and cold chain facility/biosafety lab. The 12-month funding from IHF will enable prospective, multicentric performance and cost-effectiveness evaluation of the RDT at a discounted price of ₹200 per piece for government procurements. The other platform developed by Medprime Technologies involves an artificial intelligence-powered software for faster and cost-effective detection and differentiation between malarial parasites.
Today: December 9, 2023